Branched-chain alkanols as skin permeation enhancers: Quantitative structure-activity relationships

Pharmazie

Volumn 61, Issue 4, 2006, Pages 298-300

  Ding, B Y ^a   Fu, Xuchun C ^b   Liang, W Q ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY CITY COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKANOL; BRANCHED CHAIN ALKYL GROUP; HEPTANOL; HEXANOL; NONANOL; OCTANOL; PENETRATION ENHANCING AGENT;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; LINEAR REGRESSION ANALYSIS; LIPOPHILICITY; PHYSICAL CHEMISTRY; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SKIN; SKIN PERMEABILITY; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ALCOHOLS; ALKANES; ANIMALS; CHEMISTRY, PHYSICAL; DRUG CARRIERS; LINEAR MODELS; MICE; MICE, INBRED HRS; SKIN ABSORPTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33645798085     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Aungst B, Rogers N, Shefter E (1986) Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int J Pharm 33: 225-234.
2. Chang SL, Banga AK (1998) Transdermal iontophoretic delivery of hydrocortisone from cyclodextrin solutions. J Pharm Pharmacol 50: 635-640.
3. Chantasart D, Li SK, He N, Warner KS, Prakongpan S, Higuchi WI (2004) Mechanistic studies of branched-chain alkanols as skin permeation enhancers. J Pharm Sci 93: 762-779.
4. Cho YJ, Choi HK (1998) Enhancement of percutaneous absorption of ketoprofen: effect of vehicles and adhesive matrix. Int J Pharm 169: 95-104.
5. Kim N, El-Khalili M, Henary MM, Strekowski L, Michniak BB (1999) Percutaneous penetration enhancement activity of aromatic 5,5-dimethyl- iminosulfuranes. Int J Pharm 187: 219-229.
6. Kier LB, Hall LH (1976) Molecular Connectivity in Chemistry and Drug Research. Academic, New York, N.Y.
7. Kanikkannan N, Kandimalla K, Lamba SS, Singh M (2000) Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr Med Chem 7: 593-608.
8. Kanikkannan N, Singh M (2002) Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. Int J Pharm 248: 219-228.
9. Morimoto K, Iwakura Y, Nakatani E, Miyazaki M, Tojima H (1992) Effects of proteolytic enzyme inhibitors as absorption enhancers on the transdermal iontophoretic delivery of calcitonin in rats. J Pharm Pharmacol 44: 216-218.
10. Mezel M (1985) Liposomes as a skin drug delivery system. In: Breimer DD, Speiser P (Eds.), Topics in Pharmaceutical Sciences. Elsevier, Amsterdam, pp. 345-358.
11. Smith EW, Maibach HI (1995) Percutaneous penetration enhancers: the fundamentals. In: Smith EW, Maibach HI (Eds.), Percutaneous Penetration Enhancers. CRC Press, Boca Raton, FL, pp. 1-4.
12. Sloan KB, Selk S, Haslam J, Caldwell L, Shaffer R (1984) Acyloxyamines as prodrugs of anti-inflammatory carboxylic acids for improved delivery through skin. J Pharm Sci 73: 1734-1737.
13. Wallace JM, Lowell HH, Lemont BK (1975) Molecular connectivity III: relationship to partition coefficients. J Pharm Sci 64: 1978-1981.